A meta-analysis of more than 20 phase 3 trials found no clear survival differences by sex or age in metastatic NSCLC but ...
New retrospective analysis showed Orca-T with reduced intensity conditioning (RIC) demonstrated favorable OS, RFS and GRFS compared to PTCyCompany announced first patients dosed in the Phase 2 ...
A study reveals that omega-3 can slow down DNA aging, pointing to a minimal formula against the passage of time.
MedPage Today on MSN
New emphasis on N1 lymph nodes dawns on lung resections
Observational study finds more pathologic nodal upstaging with more nodes sampled ...
Quince Therapeutics’ novel method of delivering steroids in a patient’s own red blood cells has turned out to be a bust in ataxia-telangiectasia (A-T), a rare inherited disorder. | Quince Therapeutics ...
The FDA is reviewing zanzalintinib combined with atezolizumab for metastatic colorectal cancer, with a PDUFA target date of December 3, 2026. The STELLAR-303 trial showed significant overall survival ...
Investigators trialed injection of an immune-stimulating substance (poly-ICLC) into the prostate gland using MRI-ultrasound fusion technology in patients scheduled to undergo radical prostatectomy.
A key outcome from lung cancer screening studies is the concept of ‘stage-shift’ seen in screen-detected cancers compared ...
这种双重作用机制使CELMoD药物有望成为新的治疗基石。临床前研究显示，CELMoD药物IBER可使MM细胞表面CD38表达水平升高，从而增强抗CD38单抗的疗效；同时，它还可改善CAR-T细胞扩增率，并增强CAR-T细胞功能，从而提升治疗应答率、缓解深度和持久性 [2] [3] [4]。总之，CELMoD药物在早期研究中已表现出广泛的联合治疗潜力，有望为追求更深层次的疾病缓解提供新策略。
Amgen (NASDAQ: AMGN) today announced financial results for the fourth quarter and full year of 2025 versus the ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果